{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:06:18Z","timestamp":1774958778918,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001707"],"award-info":[{"award-number":["82001707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373209"],"award-info":[{"award-number":["81373209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["20YF1425700"],"award-info":[{"award-number":["20YF1425700"]}]},{"name":"Shanghai Sailing Program","award":["22YF1424000"],"award-info":[{"award-number":["22YF1424000"]}]},{"name":"Ren Ji Program","award":["RJTJ24-MS-020"],"award-info":[{"award-number":["RJTJ24-MS-020"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YG2023ZD09"],"award-info":[{"award-number":["YG2023ZD09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06597-x","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:11:10Z","timestamp":1748855470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["IL-6R blockade combined with immunosuppressants alleviates adult-onset Still\u2019s disease through immune remodeling: a mass cytometry study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0066-9153","authenticated-orcid":false,"given":"Ruru","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"12","key":"6597_CR1","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/ard-2024-225851","volume":"83","author":"B Fautrel","year":"2024","unstructured":"Fautrel B, Mitrovic S, De Matteis A, et al. EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease. Ann Rheum Dis. 2024;83(12):1614\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6597_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Seve P. Adult-onset Still\u2019s disease. Autoimmun Rev. 2014;13(7):708\u201322.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"6597_CR3","first-page":"257","volume":"84","author":"S Bindoli","year":"2024","unstructured":"Bindoli S, Baggio C, Doria A, Sfriso P. Adult-onset still\u2019s disease (AOSD): advances in understanding pathophysiology. Genet Emerg Treat Opt Drugs. 2024;84(3):257\u201374.","journal-title":"Genet Emerg Treat Opt Drugs"},{"issue":"10","key":"6597_CR4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still\u2019s disease. Ann Rheum Dis. 2004;63(10):1300\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6597_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","volume":"30","author":"S Castaneda","year":"2016","unstructured":"Castaneda S, Blanco R, Gonzalez-Gay MA. Adult-onset Still\u2019s disease: advances in the treatment. Best Pract Res Clin Rheumatol. 2016;30(2):222\u201338.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"6597_CR6","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","volume":"62","author":"S Franchini","year":"2010","unstructured":"Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease. Arthritis Rheum. 2010;62(8):2530\u20135.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6597_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4049\/jimmunol.1701025","volume":"200","author":"MA Kunicki","year":"2018","unstructured":"Kunicki MA, Amaya Hernandez LC, Davis KL, Bacchetta R, Roncarolo MG. Identity and diversity of human peripheral Th and T regulatory cells defined by single-cell mass cytometry. J Immunol. 2018;200(1):336\u201346.","journal-title":"J Immunol"},{"issue":"3","key":"6597_CR8","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19(3):424\u201330.","journal-title":"J Rheumatol"},{"issue":"1","key":"6597_CR9","doi-asserted-by":"publisher","first-page":"13477","DOI":"10.1038\/s41598-017-13639-y","volume":"7","author":"T Li","year":"2017","unstructured":"Li T, Gu L, Wang X, et al. A pilot study on tocilizumab for treating refractory adult-onset still\u2019s disease. Sci Rep. 2017;7(1):13477.","journal-title":"Sci Rep"},{"key":"6597_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymeth.2019.01.018","volume":"158","author":"DB Cook","year":"2019","unstructured":"Cook DB, McLucas BC, Montoya LA, et al. Multiplexing protein and gene level measurements on a single Luminex platform. Methods. 2019;158:27\u201332.","journal-title":"Methods"},{"key":"6597_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3389\/fimmu.2019.01571","volume":"10","author":"T Zhang","year":"2019","unstructured":"Zhang T, Lv J, Tan Z, et al. Immunocyte profiling using single-cell mass cytometry reveals EpCAM(+) CD4(+) T cells abnormal in colon cancer. Front Immunol. 2019;10:1571.","journal-title":"Front Immunol"},{"key":"6597_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cpim.31","author":"TM Brodie","year":"2017","unstructured":"Brodie TM, Tosevski V. High-dimensional single-cell analysis with mass cytometry. Curr Protoc Immunol. 2017. https:\/\/doi.org\/10.1002\/cpim.31.","journal-title":"Curr Protoc Immunol"},{"key":"6597_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125306","author":"R Guo","year":"2019","unstructured":"Guo R, Zhang T, Meng X, et al. Lymphocyte mass cytometry identifies a CD3-CD4+ cell subset with a potential role in psoriasis. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.125306.","journal-title":"JCI Insight"},{"issue":"4","key":"6597_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/2472630319834057","volume":"24","author":"H Meng","year":"2019","unstructured":"Meng H, Warden A, Zhang L, et al. A mass-ratiometry-based CD45 barcoding method for mass cytometry detection. SLAS Technol. 2019;24(4):408\u201319.","journal-title":"SLAS Technol"},{"issue":"7","key":"6597_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nprot.2016.066","volume":"11","author":"B Anchang","year":"2016","unstructured":"Anchang B, Hart TD, Bendall SC, et al. Visualization and cellular hierarchy inference of single-cell data using SPADE. Nat Protoc. 2016;11(7):1264\u201379.","journal-title":"Nat Protoc"},{"issue":"1","key":"6597_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine JH, Simonds EF, Bendall SC, et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell. 2015;162(1):184\u201397.","journal-title":"Cell"},{"issue":"9","key":"6597_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005112","volume":"12","author":"H Chen","year":"2016","unstructured":"Chen H, Lau MC, Wong MT, Newell EW, Poidinger M, Chen J. Cytofkit: a bioconductor package for an integrated mass cytometry data analysis pipeline. PLoS Comput Biol. 2016;12(9): e1005112.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"6597_CR18","first-page":"780","volume":"165","author":"MH Spitzer","year":"2016","unstructured":"Spitzer MH, Nolan GP. Mass cytometry: single cells. Many Features Cell. 2016;165(4):780\u201391.","journal-title":"Many Features Cell"},{"issue":"10","key":"6597_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nbt.1991","volume":"29","author":"P Qiu","year":"2011","unstructured":"Qiu P, Simonds EF, Bendall SC, et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol. 2011;29(10):886\u201391.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"6597_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/JLB.MR0618-226R","volume":"105","author":"E Burgueno-Bucio","year":"2019","unstructured":"Burgueno-Bucio E, Mier-Aguilar CA, Soldevila G. The multiple faces of CD5. J Leukoc Biol. 2019;105(5):891\u2013904.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"6597_CR21","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/ar3794","volume":"14","author":"U Fagin","year":"2012","unstructured":"Fagin U, Pitann S, Gross WL, Lamprecht P. Increased frequency of CCR4+ and CCR6+ memory T-cells including CCR7+CD45RAmed very early memory cells in granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Res Ther. 2012;14(2):R73.","journal-title":"Arthritis Res Ther"},{"key":"6597_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","volume":"87","author":"R Stadhouders","year":"2018","unstructured":"Stadhouders R, Lubberts E, Hendriks RW. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J Autoimmun. 2018;87:1\u201315.","journal-title":"J Autoimmun"},{"issue":"8","key":"6597_CR23","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/eji.200940257","volume":"40","author":"L Maggi","year":"2010","unstructured":"Maggi L, Santarlasci V, Capone M, et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol. 2010;40(8):2174\u201381.","journal-title":"Eur J Immunol"},{"issue":"7","key":"6597_CR24","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1073\/pnas.0914839107","volume":"107","author":"E Billerbeck","year":"2010","unstructured":"Billerbeck E, Kang YH, Walker L, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A. 2010;107(7):3006\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"6597_CR25","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/leu.2016.226","volume":"30","author":"M Seifert","year":"2016","unstructured":"Seifert M, Kuppers R. Human memory B cells. Leukemia. 2016;30(12):2283\u201392.","journal-title":"Leukemia"},{"issue":"12","key":"6597_CR26","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/intimm\/13.12.1583","volume":"13","author":"A Rivera","year":"2001","unstructured":"Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol. 2001;13(12):1583\u201393.","journal-title":"Int Immunol"},{"issue":"5","key":"6597_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/JLB.1RU0717-299RR","volume":"103","author":"W Zhiming","year":"2018","unstructured":"Zhiming W, Luman W, Tingting Q, Yiwei C. Chemokines and receptors in intestinal B lymphocytes. J Leukoc Biol. 2018;103(5):807\u201319.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"6597_CR28","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2174\/18715206113139990078","volume":"13","author":"A Ahmad","year":"2013","unstructured":"Ahmad A, Biersack B, Li Y, et al. Targeted regulation of PI3K\/Akt\/mTOR\/NF-kappaB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. Anticancer Agents Med Chem. 2013;13(7):1002\u201313.","journal-title":"Anticancer Agents Med Chem"},{"issue":"11","key":"6597_CR29","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008;22(11):1490\u2013500.","journal-title":"Genes Dev"},{"issue":"12","key":"6597_CR30","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s40265-018-0956-9","volume":"78","author":"P Sfriso","year":"2018","unstructured":"Sfriso P, Bindoli S, Galozzi P. Adult-onset still\u2019s disease: molecular pathophysiology and therapeutic advances. Drugs. 2018;78(12):1187\u201395.","journal-title":"Drugs"},{"issue":"11","key":"6597_CR31","first-page":"2422","volume":"30","author":"JH Choi","year":"2003","unstructured":"Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still\u2019s disease. J Rheumatol. 2003;30(11):2422\u20137.","journal-title":"J Rheumatol"},{"issue":"2","key":"6597_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/rheumatology\/kez392","volume":"59","author":"H Yamada","year":"2020","unstructured":"Yamada H, Kaneko Y, Tamai H, Takeuchi T. Biomarkers for disease flare in patients with adult-onset Still\u2019s disease undergoing treatment with tocilizumab. Rheumatology (Oxford). 2020;59(2):440\u20132.","journal-title":"Rheumatology (Oxford)"},{"key":"6597_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.881431","volume":"9","author":"S Rao","year":"2022","unstructured":"Rao S, Tsang LS, Zhao M, Shi W, Lu Q. Adult-onset Still\u2019s disease: a disease at the crossroad of innate immunity and autoimmunity. Front Med (Lausanne). 2022;9: 881431.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"6597_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/14397595.2014.973659","volume":"25","author":"N Nishina","year":"2015","unstructured":"Nishina N, Kaneko Y, Kameda H, Takeuchi T. The effect of tocilizumab on preventing relapses in adult-onset Still\u2019s disease: a retrospective, single-center study. Mod Rheumatol. 2015;25(3):401\u20134.","journal-title":"Mod Rheumatol"},{"issue":"4","key":"6597_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting Interleukin-6 Signaling in Clinic. Immunity. 2019;50(4):1007\u201323.","journal-title":"Immunity"},{"issue":"4","key":"6597_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/14712598.2019.1590334","volume":"19","author":"S Castaneda","year":"2019","unstructured":"Castaneda S, Martinez-Quintanilla D, Martin-Varillas JL, Garcia-Castaneda N, Atienza-Mateo B, Gonzalez-Gay MA. Tocilizumab for the treatment of adult-onset Still\u2019s disease. Expert Opin Biol Ther. 2019;19(4):273\u201386.","journal-title":"Expert Opin Biol Ther"},{"key":"6597_CR37","doi-asserted-by":"publisher","first-page":"205873841879128","DOI":"10.1177\/2058738418791284","volume":"32","author":"JY Jung","year":"2018","unstructured":"Jung JY, Choi B, Sayeed HM, et al. Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still\u2019s disease. Int J Immunopathol Pharmacol. 2018;32:2058738418791284.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"11","key":"6597_CR38","first-page":"612","volume":"18","author":"S Onuora","year":"2022","unstructured":"Onuora S. Immune cell profiles stratify AOSD endotypes. Nat Rev Rheumatol. 2022;18(11):612.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"6597_CR39","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/rheumatology\/keac439","volume":"62","author":"R Guo","year":"2023","unstructured":"Guo R, Liu X, Li Y, et al. AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis. Rheumatology (Oxford). 2023;62(4):1636\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"6597_CR40","first-page":"74","volume":"37","author":"J Torres-Ruiz","year":"2019","unstructured":"Torres-Ruiz J, Carrillo-Vazquez DA, Tapia-Rodriguez M, Garcia-Galicia JA, Alcocer-Varela J, Gomez-Martin D. The role of low density granulocytes and NETosis in the pathogenesis of adult-onset Still\u2019s Disease. Clin Exp Rheumatol. 2019;37(6):74\u201382.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"6597_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","volume":"77","author":"C Gabay","year":"2018","unstructured":"Gabay C, Fautrel B, Rech J, et al. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\u2019s disease. Ann Rheum Dis. 2018;77(6):840\u20137.","journal-title":"Ann Rheum Dis"},{"key":"6597_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.molimm.2017.07.004","volume":"90","author":"Q Bie","year":"2017","unstructured":"Bie Q, Jin C, Zhang B, Dong H. IL-17B: a new area of study in the IL-17 family. Mol Immunol. 2017;90:50\u20136.","journal-title":"Mol Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06597-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:11:11Z","timestamp":1748855471000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06597-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6597"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06597-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and with the ethical standards of the institutional research committee. Ethical approval was given by the Renji Hospital Ethics Committee, Shanghai Jiao Tong University School of Medicine with the following ethics number: [2017]201. The Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, approved the study design and the acquisition of blood from recruited patients. Written informed consent was obtained from patients prior to their enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"610"}}